PNPLA3 and metabolic dysfunction-associated steatotic liver disease: In addition, obesity interacts with PNPLA3 I148M genetic variation to elevate liver fat content and NAFLD susceptibility, and to increase the risk of liver injury, liver fibrosis and HCC (120–122).